Message from Icon Oncology CEO on COVID-19
Announced in February this year, SAJO is now included in the list of accredited journals distributed by the Department. This is good news for local clinical researchers and Universities wanting to access much needed funding for cancer research.
Professor Raymond Abratt, Icon Oncology’s Head of Clinical Governance and Chief Editor of the SAJO, says this recognition gives a voice to clinical oncology researchers in our region; “Peer reviewed publications are the gold standard for evidence-based medicine and the accreditation will be welcomed by Universities which can apply for funding to the DHET for published research in the journal,” says Abratt.
Congratulating Professor Abratt and the editorial team, Dr Ernst Marais, COO of Icon Oncology says: “The accreditation of SAJO is an important benchmark for meeting high scientific standards and acknowledges the important contribution of the journal to our regional and global oncology knowledge.”
The online journal publishes high quality articles on all aspects of oncology and supports a multi-disciplinary approach to cancer care and research.
“Importantly, it is an open access journal allowing all content to be freely available without charge to individuals as well as institutions,” concludes Abratt.
For more information about the SAJO, visit www.sajo.org.za.